J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keadle, T. L.
Right arrow Articles by Stuart, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keadle, T. L.
Right arrow Articles by Stuart, P. M.
Agricola
Right arrow Articles by Keadle, T. L.
Right arrow Articles by Stuart, P. M.
Journal of General Virology (2002), 83, 2361-2365.
© 2002 Society for General Microbiology


Animal: DNA Viruses

Therapeutic vaccination with vhs- herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice

Tammie L. Keadle1, Keith A. Laycock1, Jessica L. Morris1, David A. Leib1, Lynda A. Morrisona,1, Jay S. Pepose1 and Patrick M. Stuart1

Washington University School of Medicine, Department of Ophthalmology and Visual Sciences, Box 8096, 660 South Euclid, St Louis, MO 63110, USA1

Author for correspondence: Patrick Stuart. Fax +1 314 362 6985. e-mail stuart{at}vision.wustl.edu

Virion host shutoff (vhs)-deficient herpes simplex virus (HSV) was tested as a therapeutic vaccine in a mouse model of UV light-induced recurrent herpetic stromal keratitis. Four weeks after primary corneal infection, mice were vaccinated intraperitoneally with vhs- vaccine or control. Four weeks after vaccination, the eyes of latently infected mice were UV-B irradiated to induce recurrent virus shedding and disease. Post-irradiation corneal opacity in latently infected, vhs--vaccinated mice was significantly reduced compared to control-vaccinated mice (P=0·007 to 0·035). The incidence and duration of recurrent virus shedding were the same in both groups. Antibody titres were increased (P=0·05) and delayed type hypersensitive responses were unaffected by vhs- vaccination. Combined with studies using different vaccination timing and vhs- genotypes, these data suggest that deletion of vhs is a useful strategy in the development of a therapeutic HSV vaccine, and that temporal and genetic factors influence vaccination outcome.




This article has been cited by other articles:


Home page
J. Virol.Home page
T. J. Pasieka, C. Cilloniz, B. Lu, T. H. Teal, S. C. Proll, M. G. Katze, and D. A. Leib
Host Responses to Wild-Type and Attenuated Herpes Simplex Virus Infection in the Absence of Stat1
J. Virol., March 1, 2009; 83(5): 2075 - 2087.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Sarma, D. Agarwal, L. A. Shiflett, and G. S. Read
Small Interfering RNAs That Deplete the Cellular Translation Factor eIF4H Impede mRNA Degradation by the Virion Host Shutoff Protein of Herpes Simplex Virus
J. Virol., July 1, 2008; 82(13): 6600 - 6609.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Pasieka, B. Lu, and D. A. Leib
Enhanced Pathogenesis of an Attenuated Herpes Simplex Virus for Mice Lacking Stat1
J. Virol., June 15, 2008; 82(12): 6052 - 6055.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Pasieka, B. Lu, S. D. Crosby, K. M. Wylie, L. A. Morrison, D. E. Alexander, V. D. Menachery, and D. A. Leib
Herpes Simplex Virus Virion Host Shutoff Attenuates Establishment of the Antiviral State
J. Virol., June 1, 2008; 82(11): 5527 - 5535.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Feng, D. N. Everly Jr., and G. S. Read
mRNA Decay during Herpes Simplex Virus (HSV) Infections: Protein-Protein Interactions Involving the HSV Virion Host Shutoff Protein and Translation Factors eIF4H and eIF4A
J. Virol., August 1, 2005; 79(15): 9651 - 9664.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry, J. N. Blattman, and R. Ahmed
Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic Vaccination
J. Virol., July 15, 2005; 79(14): 8960 - 8968.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry and R. Ahmed
Memory CD8 T-Cell Differentiation during Viral Infection
J. Virol., June 1, 2004; 78(11): 5535 - 5545.
[Full Text] [PDF]


Home page
CVIHome page
L. Aurelian
Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?
Clin. Vaccine Immunol., May 1, 2004; 11(3): 437 - 445.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2002 by the Society for General Microbiology.